Yahoo · Sep 16, 2026
AT&T Teams Up With LifeMD for Virtual Health Care: Can it Aid Shares?
T expands customer benefits with complimentary LifeMD memberships, offering virtual care, prescriptions and pharmacy services.
LF
NYSE · LFMDP
LifeMD, Inc.
Healthcare · Medical - Pharmaceuticals
$22.38
Up+$0.02 (+0.09%)
Updated Oct 10, 2026, 8:25 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 994.03M
- P/E ratio
- -34.8
- Dividend yield
- 9.91%
- 52-week range
- $20.97 – $24.20
- Volume
- 359
- Avg. volume
- 1.64K
Price performance · LFMDP
LFMDP price history
1M range · 16 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
LFMDP closed at $22.38 after 16 trading sessions, down 1.97% for the selected period.
- Last close
- $22.38
- Period change
- -1.97%
- Period low
- $22.36
- Period high
- $23.35
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $22.48 | $22.48 | $22.38 | $22.38 | 359 |
| Oct 8, 2026 | $22.35 | $22.40 | $22.35 | $22.36 | 968.49 |
| Oct 7, 2026 | $21.965 | $22.40 | $21.965 | $22.40 | 1.77K |
| Oct 6, 2026 | $22.69 | $23.35 | $20.97 | $23.35 | 6.31K |
| Oct 5, 2026 | $22.80 | $23.05 | $22.80 | $22.86 | 2.37K |
| Oct 2, 2026 | $22.75 | $22.75 | $22.52 | $22.7399 | 2.01K |
| Oct 1, 2026 | $23.3275 | $23.33 | $23.1444 | $23.1444 | 4.37K |
| Sep 29, 2026 | $23.33 | $23.33 | $23.05 | $23.0545 | 4.98K |
| Sep 25, 2026 | $23.32 | $23.32 | $23.1424 | $23.149 | 532.21 |
| Sep 24, 2026 | $23.20 | $23.20 | $23.20 | $23.20 | 1.04K |
| Sep 23, 2026 | $23.35 | $23.35 | $23.2142 | $23.2142 | 695.21 |
| Sep 22, 2026 | $23.10 | $23.35 | $23.0942 | $23.35 | 2.85K |
| Sep 21, 2026 | $23.10 | $23.10 | $23.075 | $23.09 | 1.68K |
| Sep 17, 2026 | $22.925 | $23.175 | $22.925 | $23.1442 | 1.57K |
| Sep 15, 2026 | $22.87 | $23.32 | $22.79 | $23.32 | 1.05K |
| Sep 14, 2026 | $22.83 | $22.83 | $22.83 | $22.83 | 314.61 |
Latest LFMDP news
The latest Smart Investors Daily articles mentioning LFMDP.
Stock researchCompany · Overview
Company
Market Activity
Research & News
LFMDP research
Overview
Company profile and research snapshot.
Company profile
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $57.55
- Implied upside
- —
- Analysts
- 14
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 17, 2026 | HC Wainwright & Co. | Buy | — |
| Aug 7, 2026 | HC Wainwright & Co. | Buy | — |
| Aug 6, 2026 | B. Riley Securities | Buy | — |
| Aug 6, 2026 | BTIG | Buy | — |
| May 26, 2026 | HC Wainwright & Co. | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Jan 23, 2026
How The New LifeMD (LFMD) Price Target Is Shaping The Investment Story
What the New LifeMD Price Target Tells You Analysts have updated their price target for LifeMD, marking a key shift in how the stock is being framed and discussed. This change reflects a refreshed view of the company that pulls together recent business developments and expectations already circulating in the market. Stay tuned to see how you can keep on top of future price target moves and the evolving narrative around LifeMD from here. Analyst Price Targets don't always capture the full...
Yahoo · Jan 14, 2026
BofA Maintains an Underperform Rating on Hims & Hers Health, Inc. (HIMS)
Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Best Beauty Stocks to Buy Right Now. TheFly reported on January 8, 2026, that BofA reduced the price target for Hims & Hers Health, Inc. (NYSE:HIMS) to $29 from $32. It retained an Underperform rating on the stock. The firm claims that the consensus expectations […]
defenseworld.net · Dec 12, 2025
LifeMD (NASDAQ:LFMDP) Trading 0.5% Higher – Time to Buy?
LifeMD, Inc. (NASDAQ: LFMDP - Get Free Report)'s share price traded up 0.5% on Thursday. The company traded as high as $22.63 and last traded at $22.75. 656 shares changed hands during mid-day trading, a decline of 81% from the average session volume of 3,477 shares. The stock had previously closed at $22.63. LifeMD Stock
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
